Registration is open for the Therapy Acceleration Program (TAP) – The Leukemia and Lymphoma Society
The Leukemia and Lymphoma Society shared a post on LinkedIn:
“What does it take to accelerate progress for acute myeloid leukemia (AML) patients? Let’s talk about it.
Join our Therapy Acceleration Program (TAP) team with LLS Staff and biotech partners for a live, one-hour discussion about how collaboration is moving the needle for patients on Friday, 1/31 at 12 PM EST/9 AM PST.
You can expect to hear from:
Lawrence Mayer, PhD – Celator Pharmaceuticals
Ashley Yocum, PhD – LLS Beat AML
Ann Cahill Collins, PA – LLS PedAL
Stephan Braun, MD, PhD – ImCheck Therapeutics
Tricia Hernandez, Director of Community Engagement at The Leukemia and Lymphoma Society, shared this post, adding:
“I am looking forward to hearing from this amazing panel of experts! Join us!”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023